Order Article Reprints

Hu W, Zhang L, Ferri-Borgogno S, Kwan S-Y, Lewis KE, Cun HT, Yeung T-L, Soliman PT, Tarapore RS, Allen JE, et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers. 2020; 12(9):2436. https://doi.org/10.3390/cancers12092436

Hu, Wen, Li Zhang, Sammy Ferri-Borgogno, Suet-Ying Kwan, Kelsey E. Lewis, Han T. Cun, Tsz-Lun Yeung, Pamela T. Soliman, Rohinton S. Tarapore, Joshua E. Allen, and et al. 2020. "Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype" Cancers 12, no. 9: 2436. https://doi.org/10.3390/cancers12092436

Hu, W., Zhang, L., Ferri-Borgogno, S., Kwan, S.-Y., Lewis, K. E., Cun, H. T., Yeung, T.-L., Soliman, P. T., Tarapore, R. S., Allen, J. E., Guan, X., Lu, K. H., Mok, S. C., & Au-Yeung, C.-L. (2020). Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers, 12(9), 2436. https://doi.org/10.3390/cancers12092436